# LACTIC ACID

URL: https://app.greenveil.ai/ingredients/ingredient_unii_33_x04_xa5_at
Categories: pharma
Identifier: cfr:21 CFR 184.1061

> LACTIC ACID. Route: INTRACARDIAC; Dosage form: INJECTION; Potency: 0.01 %w/v Assessed from 23 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: INTRACARDIAC; Dosage form: INJECTION; Potency: 0.01 %w/v

## Regulatory status

- US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 1.16 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 2232 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: 44 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 50 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 192 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: ADJ PH
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 10 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 21 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 5.7 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: ADJ PH
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 7.22 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION; Potency: 0.7 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: 0.81 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 19 active drug products and 24 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._